Medical cannabis

By

22-07-2026

States Expand First Responder PTSD Treatment Options to Include Cannabis and Psychedelics

A quiet but significant policy shift is moving through state legislatures in 2025, as lawmakers approve measures that go well beyond conventional therapy and prescription medication to address

• medical cannabis

By

02-07-2026

IM Cannabis Closes Convertible Note Financing as Capital Pressures Mount

IM Cannabis Corp. has closed a US$225,000 convertible note financing through a private placement with an institutional lender, the company announced July 1, 2026. The deal, structured as a note with

• IM Cannabis Corp.

By

01-07-2026

FDA Admits Cannabis Fails Old Medical-Value Test as DEA Hearing Sharpens Rescheduling Fight

The second day of the Drug Enforcement Administration's administrative hearing on cannabis rescheduling turned confrontational in the most substantive way possible: opponents of marijuana reform

• DEA hearing

By

15-06-2026

Israeli Cannabis Company Expands Into U.S. Genetics and German Markets Through Botanico Deal

InterCure Ltd., the Nasdaq- and Tel Aviv-listed medical cannabis company, has closed the first tranche of its acquisition of Botanico Ltd. - known commercially as ISHI - an Israeli cannabis

• InterCure Ltd.